Vivo Capital Surplus Fund VIII, L.P., 10% Owner at IMPEL NEUROPHARMA INC (IMPL), bought 1,386,646 shares at $15.00 ($10.0M) on 2021-04-27, disclosed to the SEC on 2021-04-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 710,190 | $0 | 0.0% |
| 2 | $13.50 | 12,311 | $166K | 1.7% |
| 3 | $13.50 | 89,145 | $1.2M | 12.0% |
| 4 | $15.00 | 69,380 | $1.0M | 10.4% |
| 5 | $15.00 | 505,620 | $7.6M | 75.9% |
| Total | $7.21 avg | 1,386,646 |
| $10.0M |
| 100% |
| Filing → |
| TERN | BUY | 2022-08-16 | $10.3M | — | Filing → |
| ALGS | BUY | 2020-10-20 | $8.3M | — | Filing → |
| CRNX | SELL | 2020-04-17 | $10.1M | — | Filing → |